Web51 to 200 Employees. Type: Company - Public (NBY) Industry: Biotech & Pharmaceuticals. Revenue: $5 to $25 million (USD) Competitors: Unknown. NovaBay Pharmaceuticals is a biopharmaceutical company that is commercializing and developing non-antibiotic anti-infective products that address unmet therapeutic needs of the global topical anti ... Webnovabay .com. NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic …
Working at NovaBay Pharmaceuticals Inc: Employee Reviews
WebNovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor’s Eczema Balm on Return QVC® Appearance Sep 09, 2024 NovaBay … WebMar 14, 2024 · NovaBay Pharmaceuticals, Inc. develops and sells problem-solving, accessible solutions for improved well-being. Our leading product, Avenova® … csg diss track
NovaBay Pharmaceuticals LinkedIn
WebMar 27, 2024 · NovaBay recorded a loss attributable to common shareholders for the 2024 fourth quarter of $3.5 million or $0.13 per share. This compares with a net loss for the 2024 fourth quarter of $1.3... WebMar 31, 2024 · NovaBay Pharmaceuticals, Inc. filed its 10-K on Mar 31, 2024 for the period ending Dec 31, 2024. In this report its auditor, WithumSmith+Brown, PC , gave an unqualified opinion expressing doubt that... Advanced search Log in. Forgot password ? Remember ... WebEMERYVILLE, Calif. (April 20, 2024) – NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces an agreement with Shenzhen Microprofit Biotech Co., Ltd. to become the exclusive U.S. distributor of a rapid, finger prick test to determine the presence of COVID-19 or a potential indication of antibody immunity to COVID-19. e270 food additive